Katherine Strei - Feb 22, 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role: EVP, Chief HR Officer
Signature: /s/ S. Scott Lieberman, Attorney-in-fact
Stock symbol: EBS
Transactions as of: Feb 22, 2022
Transactions value $: -$68,244
Form type: 4
Date filed: 2/24/2022, 05:47 PM
Next filing: Feb 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EBS	Common Stock	Award	$0	+1.26K	+3.99%	$0.00	32.8K	Feb 22, 2022	Direct	F1
transaction	EBS	Common Stock	Tax liability	-$68.2K	-1.62K	-4.93%	$42.23	31.1K	Feb 22, 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 4,741 shares of common stock, which is in excess of the 3,483 shares previously reported on February 28, 2019.
F2	Represents shares of common stock withheld to pay taxes.

Content

Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 4,741 shares of common stock, which is in excess of the 3,483 shares previously reported on February 28, 2019.

Represents shares of common stock withheld to pay taxes.